Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Myelin Basic Protein ELISA Kit (AC2762)
Cat.#: ASET-1351
Specifications
Description Mouse Myelin Basic Protein ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Myelin Basic Protein concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 14.19 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 300-4800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1669 Mouse Cathepsin G ELISA Kit (AC3080) Quantitative inquiry ASET-2250 Rat PCDHB5 ELISA Kit (AC3661) Quantitative inquiry ASET-1793 Human GDF11 ELISA Kit (AC3204) Quantitative inquiry ASET-2083 Human NCAM2 ELISA Kit (AC3494) Quantitative inquiry ASET-2297 Human LAR ELISA Kit (AC3708) Quantitative inquiry ASET-2541 Human CD133 ELISA Kit (AC3952) Quantitative inquiry ASET-1222 Human PDE7B ELISA Kit (AC2633) Quantitative inquiry ASET-2314 Human TNF Receptor II ELISA Kit (AC3725) Quantitative inquiry ASET-2143 Human Ephrin A3 ELISA Kit (AC3554) Quantitative inquiry ASET-1168 Human Otx2 ELISA Kit (AC2579) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket